References
- LoboRAWhere are we 10 years after the Women’s Health Initiative?J Clin Endocrinol Metab20139851771178023493433
- HershALStefanickMLStaffordRSNational use of postmenopausal hormone therapy: annual trends and response to recent evidenceJAMA20042911475314709575
- HodisHNCollinsPMackWJSchierbeckLLThe timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspectiveClimacteric201215321722822612607
- North American Menopause SocietyThe 2012 hormone therapy position statement of The North American Menopause SocietyMenopause201219325727122367731
- PanayNHamodaHAryaRSavvasMBritish Menopause Society, Women’s Health ConcernThe 2013 British Menopause Society and Women’s Health Concern recommendations on hormone replacement therapyMenopause Int2013192596823761319
- de VilliersTJPinesAPanayNUpdated 2103 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife healthClimacteric20131631633723672656
- GoldEBColvinAAvisNLongitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nationAm J Public Health20069671226123516735636
- WoodsNFMitchellESSleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health StudySleep201033453954920394324
- FreemanEWAssociations of depression with the transition to menopauseMenopause201017482382720531231
- LamontJFemale sexual health consensus clinical guidelinesJ Obstet Gynaecol Can201234876977522947409
- GregersenNJensenPTGiraldiAESexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publicationDan Med Bull200653334935317092454
- [No authors listed]NIH State-of-the-Science Conference Statement on management of menopause-related symptomsNIH Consens State Sci Statements2005221138
- ShusterLTRhodesDRGostoutBSPremature menopause or early menopause: long-term health consequencesMaturitas200965216116619733988
- HodisHNMackWJHormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesisJ Steroid Biochem Mol BiolJuly92013 [Epub ahead of print.]
- ClarksonTBMelendezGCApptSETiming hypothesis for post-menopausal hormone therapy: its origin, current status, and futureMenopause201320334235323435033
- MakiPIs timing everything? New insights into why the effect of estrogen therapy on memory might be age dependentEndocrinology201315482570257223873768
- DanielJMEstrogens, estrogen receptors, and female cognitive aging: the impact of timingHorm Behav201363223123722587940
- RossouwJEPrenticeRLMansonJEPostmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopauseJAMA2007297131465147717405972
- CauleyJARobbinsJChenZEffects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trialJAMA2003290131729173814519707
- JacksonRDLaCroixAZGassMCalcium plus vitamin D supplementation and the risk of fracturesN Engl J Med2006354766968316481635
- MargolisKLBondsDERodaboughRJEffect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone TrialDiabetologia20044771175118715252707
- KanayaAMHerringtonDVittinghoffEGlycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trialAnn Intern Med200313811912513038
- ChlebowskiRTHendrixSLLangerRDInfluence of estrogen plus progestin on breast cancer and mammography in healthy post-menopausal women: the Women’s Health Initiative randomized trialJAMA2003289243243325312824205
- SimonJAWhat’s new in hormone replacement therapy: focus on transdermal estradiol and micronized progesteroneClimacteric201215Suppl 131022432810
- de VilliersTJGassMLHainesCJGlobal Consensus Statement on menopausal hormone therapyMaturitas201374439139223497918
- StuenkelCAGassMLMansonJEA decade after the Women’s Health Initiative – the experts do agreeFertil Steril201298231331422784968
- SantenRJAllredDCArdoinSPPostmenopausal hormone therapy: an Endocrine Society scientific statementJ Clin Endocrinol Metab2010957 Suppl 1s1s6620566620
- ValdiviezoCLawsonSOuyangPAn update on menopausal hormone replacement therapy in women and cardiovascular diseaseCurr Opin Endocrinol Diabetes Obes201320214815523422240
- SitesCKL’HommedieuGDTothMJBrochuMCooperBCFairhurstPAThe effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trialJ Clin Endocrinol Metab20059052701270715687338
- ZhuLBrownWCCaiQEstrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistanceDiabetes201362242443422966069
- HendersonVWLoboRAHormone therapy and the risk of stroke: perspectives 10 years after the Women’s Health Initiative trialsClimacteric201215322923422612608
- LaCroixAZChlebowskiRTMansonJEHealth outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trialJAMA2011305131305131421467283
- RoccaWAGrossardtBRMillerVMShusterLTBrownRDJrPremature menopause or early menopause and risk of ischemic strokeMenopause201219327227721993082
- RiveraCMGrossardtBRRhodesDJRoccaWAIncreased mortality for neurological and mental diseases following early bilateral oophorectomyNeuroepidemiology2009331324019365140
- ParkerWHBroderMSChangEOvarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health studyObstet Gynecol200911351027103719384117
- RenouxCDell’anielloSGarbeESuissaSTransdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control studyBMJ2010340c251920525678
- LøkkegaardEJovanovicZHeitmannBLIncreased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse StudyArch Neurol200360101379138414568807
- StefanickMLAndersonGLMargolisKLEffects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomyJAMA2006295141647165716609086
- BeralVMillion Women Study CollaboratorsBreast cancer and hormone-replacement therapy in the Million Women StudyLancet2003362938241942712927427
- BeralVReevesGBullDGreenJBreast cancer risk in relation to the interval between menopause and starting hormone therapyJ Natl Cancer Inst2011103429630521278356
- ColditzGAHankinsonSEHunterDJThe use of estrogens and progestins and the risk of breast cancer in postmenopausal womenN Engl J Med199533224158915937753136
- ColditzGARosnerBCumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health StudyAm J Epidemiol20001521095096411092437
- ChenWYMansonJEHankinsonSEUnopposed estrogen therapy and the risk of invasive breast cancerArch Intern Med200616691027103216682578
- CanonicoMOgerEPlu-BureauGHormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER studyCirculation2007115784084517309934
- ScarabinPYOgerEPlu-BureauGEStrogen and THromboEmbolism Risk Study GroupDifferential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskLancet2003362938242843212927428
- CanonicoMPlu-BureauGLoweGDScarabinPYHormone replacement therapy and risk of venous thromboembolism in post-menopausal women: systematic review and meta-analysisBMJ200833676551227123118495631
- LaliberteFDeaKDuhMSKahlerKHRolliMLefebvrePDoes the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapyMenopause201118101052105921775912
- MakiPMCritical window hypothesis of hormone therapy and cognition: a scientific update on clinical studiesMenopause201320669570923715379
- RoccaWAGrossardtBRShusterLTOophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunityBrain Res2011137918819820965156
- SherwinBBEstrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal womenPsychoneuroendocrinology19881343453573067252
- ShumakerSALegaultCRappSREstrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trialJAMA2003289202651266212771112
- SoaresCNCan depression be a menopause-associated risk?BMC Med201087921122126
- MacBrideMBRhodesDJShusterLTVulvovaginal atrophyMayo Clin Proc2010851879420042564
- North American Menopause SocietyThe role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause SocietyMenopause2007143 Pt 135536917438512
- SimonJAKokot-KierepaMGoldsteinJNappiREVaginal health in the United States: results from the Vaginal Health: Insights, Views and Attitudes surveyMenopause201320101043104823571518
- SturdeeDWPanayNInternational Menopause Society Writing GroupRecommendations for the management of postmenopausal vaginal atrophyClimacteric201013650952220883118
- SimonJAMaamariRVUltra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophyClimacteric201316Suppl 1374323848490
- CodyJDRichardsonKMoehrerBHextallAGlazenerCMOestrogen therapy for urinary incontinence in post-menopausal womenCochrane Database Syst Rev20094CD00140519821277
- ShapiroSKellyJPRosenbergLRisk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogensN Engl J Med1985313169699722995807
- AlHilliMMHopkinsMRFamuyideAOEndometrial cancer after endometrial ablation: systematic review of medical literatureJ Minim Invasive Gynecol201118339340021545966
- CrandallCLow-dose estrogen therapy for menopausal women: a review of efficacy and safetyJ Womens Health (Larchmt)200312872374714588124
- BoothbyLADoeringPLKipersztokSBioidentical hormone therapy: a reviewMenopause200411335636715167316
- SoodRShusterLSmithRVincentAJatoiACounseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physiciansJ Am Board Fam Med201124220221021383221
- GoodmanMPAre all estrogens created equal? A review of oral vs transdermal therapyJ Womens Health (Larchmt)201221216116922011208
- ArltWAndrogen therapy in womenEur J Endocrinol2006154111116381985
- MinkinMJConsiderations in the choice of oral vs transdermal hormone therapy: a reviewJ Reprod Med200449431132015134159
- FitzpatrickLAGoodAMicronized progesterone: clinical indications and comparison with current treatmentsFertil Steril199972338939710519605
- Barrett-ConnorESloneSGreendaleGThe Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent womenMaturitas19972732612749288699
- MontplaisirJLorrainJDenesleRPetitDSleep in menopause: differential effects of two forms of hormone replacement therapyMenopause200181101611201509
- de LignieresBOral micronized progesteroneClin Ther1999211416010090424
- Sitruk-WareRBricaireCDe LignieresBYanevaHMauvais-JarvisPOral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications – a reviewContraception19873643734023327648
- The North American Menopause SocietyKEEPS Results Give New Insight Into Hormone Therapy2012 Available from: http://www.menopause.org/annual-meetings/2012-meeting/keeps-reportAccessed October 5, 2013
- FournierABerrinoFClavel-ChapelonFUnequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyBreast Cancer Res Treat2008107110311117333341
- de ZieglerDFerrianiRMoraesLABullettiCVaginal progesterone in menopause: Crinone 4% in cyclical and constant combined regimensHum Reprod200015Suppl 114915810928426
- LewisJGMcGillHPattonVMElderPACaution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal womenMaturitas20024111611809337
- Sitruk-WareRThe levonorgestrel intrauterine system for use in peri- and postmenopausal womenContraception200775Suppl 6S155S16017531609
- Haimov-KochmanRBarak-GlantzEArbelRGradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective studyMenopause200613337037616735933
- MikkolaTSClarksonTBNotelovitzMPostmenopausal hormone therapy before and after the Women’s Health Initiative study: what consequences?Ann Med200436640241315513292
- SantenRJAllredDcArdoinSPPostmenopausal hormone therapy: an Endocrine Society scientific statementJ Clin Endocrinol Metab20107957 Suppl 1s1s6610.1210/jc.2009-2509 Epub Jun 21, 201020566620
- The North American Menopause Society (menopause.org) [homepage on the Internet]Hormone Products for Postmenopausal Use in the United States and Canada Available from http://www.menopause.org/docs/professional/htcharts.pdf?sfvrsn=6Accessed December 11, 2013